| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.04. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 08.04.2026 | 746 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 08.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 08.04.2026ISIN NameCA09173B1076 BITFARMS... ► Artikel lesen | |
| GEMINA LABORATORIES Aktie jetzt für 0€ handeln | |||||
| 30.03. | XFRA 8I7: AUSSETZUNG/SUSPENSION | 164 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILGEMINA LABS LTD... ► Artikel lesen | |
| 25.03. | Gemina Laboratories Ltd: Gemina Laboratories to delist from CSE March 27 | 1 | Stockwatch | ||
| 25.03. | CSE Bulletin: Delist - Gemina Laboratories Ltd. (GLAB) | 110 | Newsfile | Le 25 mars/March 2026
Gemina Laboratories Ltd. ("Gemina") has announced it has obtained the approval of its disinterested shareholders at its annual general and special meeting held on March 13,... ► Artikel lesen | |
| 25.03. | Gemina Laboratories Ltd. Announces Delisting from the CSE | 398 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / March 25, 2026 / Gemina Laboratories Ltd. (CSE:GLAB) ("Gemina" or the "Company") announces that that the Canadian Securities Exchange (the "CSE") has approved is application... ► Artikel lesen | |
| 30.12.25 | Gemina Laboratories Ltd: Gemina arranges minimum $1-million debenture offering | 4 | Stockwatch | ||
| 30.12.25 | Gemina Laboratories Ltd.: Debenture Offering and Delisting | 479 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / December 30, 2025 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina")... ► Artikel lesen | |
| 01.10.25 | Gemina Laboratories Ltd.: Gemina Laboratories Announces Termination of Transaction | 369 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / October 1, 2025 / Gemina Laboratories Ltd. (CSE:GLAB) (the "Company" or "Gemina") announces that further to its news release dated November 13, 2024, the Company will... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 36,450 | +2,82 % | dpa-AFX-Überblick: UNTERNEHMEN vom 26.05.2026 - 15.15 Uhr | Schwerwiegende Bedenken: BP trennt sich von Verwaltungsratschef - Kursrutsch LONDON - Der britische Ölkonzern BP setzt seinen Verwaltungsratschef Albert Manifold wegen Vorwürfen vor die Tür. Als... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 35,690 | -1,95 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit einem Gesamtvolumen von rund EUR 1 Milliarde in Tranchen | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Kapitalmaßnahmen / Aktienrückkäufe
Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,34 | -1,07 % | Morgan Stanley raises BrightSpring Health price target on valuation | ||
| ALIGNMENT HEALTHCARE | 13,640 | 0,00 % | Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report | ||
| SIEMENS HEALTHINEERS | 34,040 | -0,64 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung (EU)... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 4,310 | 0,00 % | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 26,760 | -3,95 % | Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment | ||
| PROGYNY | 25,115 | -4,14 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| GENEDX | 53,07 | +2,08 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| BILLIONTOONE | 94,01 | -5,03 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| QTREX QUANTUM | 2,415 | 0,00 % | QTREX Quantum Ltd.: QTREX to Showcase Functional AME-Based Monolithic Connectivity Components for Quantum Computing Systems at Quantum.Tech World 2026 in Boston | ||
| AVEANNA HEALTHCARE | 6,470 | -9,76 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 26,100 | +0,31 % | EQS-DD: Carl Zeiss Meditec AG: Peter Kameritsch, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.05.2026 / 14:57... ► Artikel lesen | |
| JIN MEDICAL INTERNATIONAL | 3,220 | +43,75 % | Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement | CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen | |
| CO-DIAGNOSTICS | 6,240 | 0,00 % | Is Co-Diagnostics National Security's Next Diagnostic Pick? |